Category: Intellectual property
-
Microneedle System Developed to Deliver Drugs to Eyes
Researchers at Georgia Institute of Technology and Emory University in Atlanta have developed a system of microneedles to deliver drugs to the back of the eye. The research team’s findings appear in the July issue of the journal Investigative Ophthalmology & Visual Science (paid subscription required). The microneedles were devised to meet a need for…
-
Max Planck Licenses 2-D/3-D Technology for Development
Max Planck Society in Munich, Germany has licensed to TandemLaunch Technologies in Montreal, Canada a new three-dimension display technology that lets viewers see 3-D movies or games in 2-D without glasses to construct the images. Financial terms of the exclusive licensing agreement were not disclosed. Current 3-D images are presented as stereoscopic pictures, with overlapping…
-
Technology Developed to Diagnose, Treat Atrial Fibrillation
Researchers at University of California in San Diego and Los Angeles, and Indiana University have discovered that irregular heart rhythms known as atrial fibrillation are the result of small electrical sources within the heart, in the form of spinning electrical rotors or focal beats. The research team published its findings online in the Journal of…
-
National Lab Seeks Commercial Partner for Diagnostics Tool
Sandia National Lab in Livermore, California is seeking a partner to commercialize its desktop medical diagnostics technology that the lab says is faster, less expensive, and more versatile than current diagnostics tools. The SpinDx, as it is known (pictured left), can tell in minutes a patient’s white blood cell count, analyze important protein markers, and…
-
Start-Up Licenses University Patient Medical Software
The Minneapolis-based start-up Omicron Health Systems Inc. has licensed software written at University of Minnesota for clinical decision making and networking across health-care providers. Financial terms of the licensing agreement were not disclosed. Many electronic health care record systems were first designed for administrative purposes, such as billing and scheduling, and for use only by…
-
USPTO to Expand to Texas, Colorado, California
The U.S. Patent and Trademark Office (USPTO) says it will open three new satellite offices in or around Dallas-Fort Worth, Denver, and Silicon Valley, California. The three new offices will join Detroit, Michigan as satellites to USPTO’s headquarters in Alexandria, Virginia. The Detroit office is set to open on 13 July. The Denver Post reported…
-
Robot Recommends and Plays Music Based on Listener Feedback
A robotic device developed at Georgia Institute of Technology, and licensed to a start-up company in Atlanta, can recommend songs based on listeners’ tastes, and even dance to the music selected. Shimi, a musical companion derived from technology developed at Georgia Tech’s Center for Music Technology, is expected to be demonstrated today at Google’s I/O…
-
Report: Foreign Scientists Key to U.S. Innovation, Patents
A new report on the impact of immigration on innovation in the U.S. says researchers from overseas account for a large majority of the patents granted to inventors from top research universities, particularly in high-growth science and engineering fields. The report, “Patent Pending: How Immigrants Are Reinventing The American Economy,” was prepared by the Partnership…
-
GSK Licenses Nanotech Product Development Platform
The global pharmaceutical company GlaxoSmithKline (GSK) will license a nanotechnology-based product development platform created by Liquidia Technologies in North Carolina. The precise financial scale of the deal was not disclosed, but the companies say total earnings by Liquidia could reach as high as several hundred million dollars. Liquidia has built a development technology for pharmaceuticals…
-
Patent Awarded for Non-Medicinal Emphysema Treatment
Aeris Therapeutics in Woburn, Massachusetts has received a patent for its lung volume reduction technology to treat emphysema with a polymer-based hydrogel. Patent number 8,198,365 was awarded earlier this week by the U.S. Patent and Trademark Office to four inventors and assigned to Aeris Therapeutics. Emphysema is a form of chronic obstructive pulmonary disease, often triggered…